Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis Licenses Stem Cell Patents

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cellectis today said that it has licensed intellectual property covering induced Pluripotent Stem Cells (iPSCs) from iPS Academia Japan.

The non-exclusive licensing deals cover research conducted by Shinya Yamanaka of the Center for iPS Cell Research and Application at Kyoto University in Japan. iPS Academia Japan is an affiliate of Kyoto University established in 2008 to manage IP covering iPSC technologies.

The agreements allow Cellectis and its affiliates to research, develop, and commercialize research tools, human therapeutics, or prophylactics derived from iPSCs in a certain range of differentiated cell lineages.

Paris-based Cellectis said that it is the first company in the world to be licensed by iPS Academia Japan under this particular patent portfolio for human therapeutics and prophylactics. It added that its Ectycell subsidiary will use the technology to "engineer these cells and derive consistent lines of robust products both as tools and as therapeutics."

Financial and other terms of the agreements were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.